The result (SMD = 0.50; 95% CI = 0.28 to 0.73; and I2 = 57.4%) indicated that CDK1 expression was significantly higher in the PCa group (1,159 samples) than in the noncancer group (491 samples) (Figure 7(a)). Here, CDK1 is linked to posterior cortical atrophy.